Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 7 days agoFood and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine, NVX-CoV2705, for...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against ...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 7 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
New COVID Mystery? Those 'Excess Deaths'
newser· 5 days agoWith hospitals swamped at the same time, excess deaths spiked considerably from causes including heart disease, stroke, and diabetes. COVID vaccines...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday ...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 7 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 4 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc, ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 2 days agoNot only have its results become more sharply partisan, favoring Republican and conservative...